Table 3 Sensitivity and subgroups analysis based on clinical effective rate

Jadad score

0–5

18

1619

1.22

1.17, 1.27

9.05

< 0.00001

0%

4.07

1.00

1–5

18

1619

1.22

1.17, 1.27

9.05

< 0.00001

0%

4.07

1.00

2–5

14

1339

1.21

1.16, 1.27

8.14

< 0.00001

0%

2.54

1.00

3–5

7

628

1.21

1.14, 1.29

5.98

< 0.00001

0%

1.11

0.98

< 3

11

991

1.22

1.15, 1.29

6.84

< 0.00001

0%

2.98

0.98

≥ 3

7

628

1.21

1.14, 1.29

5.98

< 0.00001

0%

1.11

0.98

Dosage of STS injection

Specific dosage

9

739

1.22

1.15, 1.30

6.19

< 0.00001

0%

2.48

0.96

Dynamic range

9

880

1.21

1.14, 1.28

6.60

< 0.00001

0%

1.49

0.99

Control group measures

Using enalapril

13

1174

1.22

1.16, 1.28

7.84

< 0.00001

0%

3.59

0.99

Other medicines

5

445

1.21

1.12, 1.32

4.54

< 0.00001

0%

0.49

0.97

Intervention time

≤ 14 d

11

1050

1.22

1.15, 1.28

7.13

< 0.00001

0%

1.72

1.00

> 14 d

7

569

1.22

1.14, 1.30

5.59

< 0.00001

0%

2.35

0.89